Cargando…

Do Proton Pump Inhibitor–refractory Laryngeal Symptoms Represent a True Acid-related Disease?

Detalles Bibliográficos
Autores principales:	Hong, Kwon-Eui, Huh, Cheal Wung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Neurogastroenterology and Motility 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334205/ https://www.ncbi.nlm.nih.gov/pubmed/37417255 http://dx.doi.org/10.5056/jnm23074

Ejemplares similares

A Systematic Review and Meta-analysis of Randomized Control Trials: Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease
por: Jung, Da Hyun, et al.
Publicado: (2021)

High-resolution Manometry Determinants of Refractoriness of Reflux Symptoms to Proton Pump Inhibitor Therapy
por: Ribolsi, Mentore, et al.
Publicado: (2020)

Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
por: de Sá, Cláudia Cristina, et al.
Publicado: (2011)

Pump Proton and Laryngeal H(+)/K(+) ATPases
por: Zhang, Zhe, et al.
Publicado: (2020)

Do Proton Pump Inhibitors Decrease Calcium Absorption?
por: Hansen, Karen E, et al.
Publicado: (2010)

Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions
por: Mermelstein, Joseph, et al.
Publicado: (2018)

Do the representative beam data for TrueBeam(™) linear accelerators represent average data?
por: Tanaka, Yoshihiro, et al.
Publicado: (2019)

Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer
por: Lee, Ju-Eun, et al.
Publicado: (2023)

Proton Pump Inhibitor-unresponsive Laryngeal Symptoms Are Associated With Psychological Comorbidities and Sleep Disturbance: A Manometry and Impedance-pH Monitoring Study
por: Tseng, Wen-Hsuan, et al.
Publicado: (2023)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Clinical Significance of Risk Factors for Asymptomatic Peptic Ulcer Disease
por: Huh, Cheal Wung, et al.
Publicado: (2017)

The Pros and Cons of Helicobacter pylori Treatment: A Focus on Cardiovascular Mortality
por: Huh, Cheal Wung, et al.
Publicado: (2020)

Symptoms, the GerdQ score and patients’ characteristics do not predict gastroesophageal reflux disease in patients with proton-pump-inhibitor-refractory reflux symptoms—results from a large prospective database
por: Labenz, Joachim, et al.
Publicado: (2023)

True Croup; or Pseudo-Membranous Laryngitis
por: Goldsberry, J. A.
Publicado: (1879)

On-demand Versus Continuous Maintenance Treatment With a Proton Pump Inhibitor for Mild Gastroesophageal Reflux Disease: A Prospective Randomized Multicenter Study
por: Jung, Da Hyun, et al.
Publicado: (2023)

Meta-analysis of the efficacy of proton pump inhibitors for the symptoms of laryngopharyngeal reflux
por: Liu, C., et al.
Publicado: (2016)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Pharmacoepidemiology for nephrologists: do proton pump inhibitors cause chronic kidney disease?
por: Tomlinson, Laurie A., et al.
Publicado: (2017)

Impedance pH Guided Approach to Proton Pump Inhibitor-refractory Non-erosive Reflux Disease
por: Cho, Yu Kyung
Publicado: (2014)

Effects of rikkunshito on quality of life in patients with gastroesophageal reflux disease refractory to proton pump inhibitor therapy
por: Kawai, Takashi, et al.
Publicado: (2017)

Postthyroidectomy Throat Pain and Swallowing: Do Proton Pump Inhibitors Make a Difference?
por: Zawawi, Faisal, et al.
Publicado: (2013)

Proton-pump inhibitors do not influence clinical outcomes in patients with Staphylococcus aureus bacteremia
por: Caffrey, Aisling R., et al.
Publicado: (2019)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Potassium-competitive acid blockers - are they the next generation of proton pump inhibitors?
por: Rawla, Prashanth, et al.
Publicado: (2018)

Delayed Duodenal Perforation of an Endoscopic Mucosal Resection-Induced Ulcer due to a Foreign Body
por: Gweon, Tae-Geun, et al.
Publicado: (2019)

Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of Life
por: Takeshima, Fuminao, et al.
Publicado: (2015)

SAT-121 Secretin Stimulation Test in a Patient Receiving Proton PUMP Inhibitor Therapy- to Do or Not to Do?
por: Madhavan, Parvathy, et al.
Publicado: (2020)

Association between Proton Pump Inhibitor Use and Risk of Hepatocellular Carcinoma: A Korean Nationally Representative Cohort Study
por: Kim, Soungmun, et al.
Publicado: (2022)

Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
por: Bang, Ki Bae
Publicado: (2021)

Efficacy of vonoprazan for 24-week maintenance therapy of patients with healed reflux esophagitis refractory to proton pump inhibitors
por: Mizuno, Hideki, et al.
Publicado: (2018)

Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis
por: Lopes, Sébastien, et al.
Publicado: (2023)

'Lemonade Legs': Why do Some Patients Get Profound Hypomagnesaemia on Proton-Pump Inhibitors?
por: Atkinson, Nathan S. S., et al.
Publicado: (2015)

Do proton pump inhibitors increase mortality? A systematic review and in‐depth analysis of the evidence
por: Ben‐Eltriki, Mohamed, et al.
Publicado: (2020)

Can Nocturnal Acid-breakthrough Be Reduced by Long-acting Proton Pump Inhibitors?
por: Jeon, Hye Kyung, et al.
Publicado: (2017)

Evaluation of the pharmacokinetics of trazpiroben (TAK‐906) in the presence and absence of the proton pump inhibitor esomeprazole
por: Kaur Mukker, Jatinder, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_47fqacvfoeearuo874202r7it7